![Dennis L. McCurley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dennis L. McCurley
Financieel Directeur/CFO bij ProteoTech, Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Roger S. Flugel | M | - |
ProteoTech, Inc.
![]() ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | 9 jaar |
William T. Frantz | M | - |
ProteoTech, Inc.
![]() ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | - |
Rebecca Eagen | F | - |
ProteoTech, Inc.
![]() ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | - |
Murray Raskind | M | - |
ProteoTech, Inc.
![]() ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | - |
Maria Saraiva | F | - |
ProteoTech, Inc.
![]() ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | - |
Manfred Weigele | M | - |
ProteoTech, Inc.
![]() ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | - |
Benjamin Wolozin | M | - |
ProteoTech, Inc.
![]() ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 7 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Dennis L. McCurley
- Persoonlijk netwerk